I think so, and I think you'll get a better answer from Dr. Cohn than from me because he'll have exact.... I've met with him now five or six times about this issue, and I think he can give you exact scenarios of the way that plays out in both his research work, where people don't even want to get into research projects for drug tests because it now involves those kinds of tests.
We won't have new drugs coming onto the market because people don't want to do that. Then we have a physician in a clinical practice who is arguing with parents to ask them to get the tests so he can do his job, and they step back.
I want to get on the record that the other thing in Canada is that not only is this about the health of Canadians—and that's my primary thing—but biotech industries are emerging that Canada can be a leader in.
I talked to people from two companies. One is Sequence Bio in Newfoundland, which is a world leader on biotech information, and they're going to do a survey of 100,000 Canadians. They are desperate to have this information so they can do that testing. They feel they won't get a sample size big enough if they don't do it. In Quebec BiogeniQ is another company. These are jobs, and these are important issues that we also need to address.